GGrantIndex
← Search

Cancer Center Support Grant

$96,064P30FY2023CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07339085Trial NCT07276438Trial NCT07242365Trial NCT06650163Trial NCT06568016Trial NCT06113016Trial NCT05595499Trial NCT04205838Trial NCT04201873Trial NCT04185311Trial NCT04119024Trial NCT04106362Trial NCT04069923Trial NCT04069910Trial NCT04050215Trial NCT04007029Trial NCT03996850Trial NCT03970252Trial NCT03953157Trial NCT03904251Trial NCT03902951Trial NCT03892720Trial NCT03830918Trial NCT03825796Trial NCT03745690Trial NCT03732950Trial NCT03732352Trial NCT03672773Trial NCT03623854Trial NCT03618134Trial NCT03603223Trial NCT03601455Trial NCT03596710Trial NCT03582774Trial NCT03582475Trial NCT03541850Trial NCT03515577Trial NCT03506802Trial NCT03425461Trial NCT03411070Trial NCT03368547Trial NCT03319342Trial NCT03240861Trial NCT03202472Trial NCT03128619Trial NCT03025139Trial NCT03014804Trial NCT02940262Trial NCT02928510Trial NCT02925351Trial NCT02919332Trial NCT02902757Trial NCT02888301Trial NCT02881242Trial NCT02880020Trial NCT02879994Trial NCT02830165Trial NCT02816879Trial NCT02775292Trial NCT02756130Trial NCT02701153Trial NCT02688348Trial NCT02683200Trial NCT02672033Trial NCT02597894Trial NCT02575027Trial NCT02451865Trial NCT02336763Trial NCT02310594Trial NCT02296229Trial NCT02280161Trial NCT02263898Trial NCT02176902Trial NCT02070406Trial NCT02049593Trial NCT02048020Trial NCT02015559Trial NCT01912820Trial NCT01013285Trial NCT01005472Trial NCT00999557Trial NCT00998010Trial NCT00985192Trial NCT00955591Trial NCT00882765Trial NCT00880542Trial NCT00769470Trial NCT00706615Trial NCT00685516Trial NCT00616642Trial NCT00612066Trial NCT00601289Trial NCT00601094Trial NCT00521209Trial NCT00509431Trial NCT00471887Trial NCT00450567Trial NCT00444223Trial NCT00352001Trial NCT00349167

Abstract

ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-23-041: Administrative supplements to examine the effects of digital tools and interventions on patient-provider communication across the cancer control continuum. Development of a virtual platform for primary care physicians to rehearse conversations with patients who have an abnormal mammogram It is difficult for physicians to deliver bad news to patients, such as a cancer diagnosis. Communication skills training is limited, often taking place through workshops or standardized patients (SP). SP programs provide active learning opportunities for clinicians to solidify passive classroom learning but also introduce challenges in recruiting, training, and retaining SP, and maintaining program fidelity using different SP. We propose to develop a virtual reality (VR) communication training module for physicians that incorporates simulated SP (avatars) to address challenges using live SP. This is an innovative application of VR training in the healthcare sector. To date, VR has largely been used to enhance telehealth, train physicians to refine motor skills, and manage patient pain. As a use case, we will develop a VR training module for primary care physicians to rehearse communicating an abnormal mammography result to a patient and the evaluation that ensues. We chose this use case because it is a common and challenging communication scenario for physicians and their patients, and one we can reasonably address within a one-year timeline and limited funding allotted by this NOSI. Breast cancer is the most common incident cancer among women in the United States. Mammography is a screening tool that yields a high rate of false positives after repeat testing. Physicians need proficient interpersonal communication skills to help their patients navigate the emotions that accompany a positive screen and present for follow-up to take appropriate action for further testing and treatment if cancer is present. Our team in the UCLA Geffen School of Medicine (SOM) brings multidisciplinary expertise in primary and oncology clinical care, VR and human-centered design, and mixed methods. We will conduct in-depth interviews with primary care physicians (n=5), SOM students (n=5), and breast cancer survivors to construct journey maps (n=5) and identify ways for physicians to better communicate with patients and help them navigate medical diagnostic and treatment processes that begin with an abnormal mammography. Based on qualitative findings, we will plan out the training module using story boards to adequately capture patient diversity and potential variations in conversation streams between providers and patients, patient reactions and emotions, and physical appearances of patients. After storyboarding, we will iteratively develop a VR training module and patient avatars as a proof-of-concept and evaluate feasibility, acceptability, and usability with 10 SOM students and residents. Specific aims are to: (a) Use qualitative methodology to develop a VR communications training module; and (b) Evaluate the feasibility, acceptability, and usability of the VR module through a single arm proof-of-concept trial with medical students.

View original record on NIH RePORTER →